Molinaro Carmela, Gauvreau Danny, Hughes Gregory, Lau Stephen, Lauzon Sophie, Angelaud Rémy, O'Shea Paul D, Janey Jacob, Palucki Michael, Hoerrner Scott R, Raab Conrad E, Sidler Rick R, Belley Michel, Han Yongxin
Department of Process Research, Merck Frosst Centre for Therapeutic Research, 16711 Trans Canada Highway, Kirkland, Quebec, Canada, H9H 3L1.
J Org Chem. 2009 Sep 4;74(17):6863-6. doi: 10.1021/jo901267x.
A practical large-scale chromatography-free synthesis of EP4 antagonist MF-310, a potential new treatment for chronic inflammation, is presented. The synthetic route provided MF-310 as its sodium salt in 10 steps and 17% overall yield from commercially available pyridine dicarboxylate 7. The key features of this sequence include a unique regioselective reduction of succinimide 2 controlled by the electronic properties of a remote pyridine ring, preparation of cyclopropane carboxylic acid 3 via a Corey-Chaykovsky cyclopropanation, and a short synthesis of sulfonamide 5.
本文介绍了一种实用的大规模无色谱法合成EP4拮抗剂MF-310的方法,MF-310是一种潜在的慢性炎症新疗法。该合成路线以市售的吡啶二羧酸酯7为原料,经过10步反应,以17%的总收率得到MF-310的钠盐。该合成路线的关键特点包括:通过远程吡啶环的电子性质控制对琥珀酰亚胺2进行独特的区域选择性还原;通过Corey-Chaykovsky环丙烷化反应制备环丙烷羧酸3;以及磺胺5的短合成路线。